MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
Adenoma
/ genetics
Adult
Aged
Animals
B7-H1 Antigen
/ genetics
Cell Line, Tumor
Cell Proliferation
/ genetics
DNA-Binding Proteins
/ genetics
Female
Gene Expression Regulation, Neoplastic
/ genetics
Gene Knockout Techniques
Humans
Immunohistochemistry
Male
Mice
Middle Aged
MutS Homolog 2 Protein
/ genetics
Neoplasm Invasiveness
/ genetics
Pituitary Neoplasms
/ genetics
Rats
Transcription Factor Pit-1
/ genetics
MSH2
MSH6
PD-L1
mismatch repair gene
pituitary adenoma
tumor immunity
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Apr 2020
18 Apr 2020
Historique:
received:
01
04
2020
revised:
14
04
2020
accepted:
16
04
2020
entrez:
25
4
2020
pubmed:
25
4
2020
medline:
3
2
2021
Statut:
epublish
Résumé
Mismatch repair genes
Identifiants
pubmed: 32325698
pii: ijms21082831
doi: 10.3390/ijms21082831
pmc: PMC7215962
pii:
doi:
Substances chimiques
B7-H1 Antigen
0
CD274 protein, human
0
DNA-Binding Proteins
0
G-T mismatch-binding protein
0
POU1F1 protein, human
0
Transcription Factor Pit-1
0
MSH2 protein, human
EC 3.6.1.3
MutS Homolog 2 Protein
EC 3.6.1.3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Japan Society for the Promotion of Science
ID : JSPS KAKENHI : JP18K16243
Références
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3925-3930
pubmed: 30085142
J Clin Invest. 2003 Dec;112(11):1603-18
pubmed: 14660734
Lancet Oncol. 2016 Dec;17(12):e542-e551
pubmed: 27924752
Lancet. 2016 Apr 9;387(10027):1540-1550
pubmed: 26712084
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12293-7
pubmed: 12218188
Neurosurgery. 2007 Sep;61(3):580-4; discussion 584-5
pubmed: 17881972
Am J Surg Pathol. 2017 Mar;41(3):326-333
pubmed: 27984238
Endocr Pathol. 2015 Dec;26(4):349-55
pubmed: 26481628
J Clin Endocrinol Metab. 2018 Mar 1;103(3):1171-1179
pubmed: 29342268
Endocr Pathol. 2012 Sep;23(3):151-6
pubmed: 22569896
Endocr Relat Cancer. 2017 Apr;24(4):C5-C8
pubmed: 28264912
Lancet Oncol. 2017 Sep;18(9):1182-1191
pubmed: 28734759
Nat Clin Pract Endocrinol Metab. 2006 Apr;2(4):220-30
pubmed: 16932287
Cell Metab. 2017 Apr 4;25(4):883-897.e8
pubmed: 28380378
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
Clin Cancer Res. 2015 Sep 1;21(17):4014-21
pubmed: 26019170
Mod Pathol. 2016 Sep;29(9):1104-12
pubmed: 27198569
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Endocr J. 2017 Sep 30;64(9):895-906
pubmed: 28701629
Brain Tumor Pathol. 2018 Apr;35(2):51-56
pubmed: 29687298
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3928-3932
pubmed: 28938458
Cell. 2015 Jan 15;160(1-2):48-61
pubmed: 25594174
J Clin Endocrinol Metab. 2006 Dec;91(12):4769-75
pubmed: 16968795
Neurosurgery. 1993 Oct;33(4):610-7; discussion 617-8
pubmed: 8232800
Oncotarget. 2016 Nov 22;7(47):76565-76576
pubmed: 27655724
Mod Pathol. 2016 Feb;29(2):131-42
pubmed: 26743473
Neuro Endocrinol Lett. 2015;36(5):511-4
pubmed: 26707053
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1272-1282
pubmed: 30423170
Brain Tumor Pathol. 2018 Apr;35(2):57-61
pubmed: 29318396
J Neuropathol Exp Neurol. 2017 Oct 1;76(10):874-882
pubmed: 28922848
Nat Rev Clin Oncol. 2010 Apr;7(4):197-208
pubmed: 20177404
Mol Cancer Ther. 2015 Apr;14(4):847-56
pubmed: 25695955
Eur J Endocrinol. 2019 Dec;181(6):R235-R254
pubmed: 31658440
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2473-2489
pubmed: 30020466
J Neurooncol. 2018 Aug;139(1):89-95
pubmed: 29680903
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
Am J Surg Pathol. 2018 Feb;42(2):183-191
pubmed: 28914717
Cancer Discov. 2013 Dec;3(12):1355-63
pubmed: 24078774
Cancers (Basel). 2019 Dec 04;11(12):
pubmed: 31817110